Laura Williams

Technik-/Wissenschafts-/F&E-Leiter bei ARDELYX, INC.

Vermögen: 2 Mio $ am 30.04.2024

61 Jahre

Health Technology

Consumer Services

Aktive Positionen von Laura Williams

Unternehmen	Position	Beginn	Ende
ARDELYX, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2021	-
ARDELYX, INC.	Corporate Officer/Principal	01.11.2020	-

Unternehmen	Position	Beginn	Ende
AMAG PHARMACEUTICALS, INC.	Corporate Officer/Principal	07.09.2017	01.01.2020
Myovant Sciences, Inc. Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY.	Technik-/Wissenschafts-/F&E-Leiter	01.09.2016	01.08.2017
IMARA	Direktor/Vorstandsmitglied	30.06.2021	-
IMARA	Independent Dir/Board Member	30.06.2021	-

University of Iowa	Doctorate Degree
Mississippi State University	Undergraduate Degree
University of Washington	Graduate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1

Sektoral

Health Technology	5
Consumer Services	4

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ARDELYX, INC.	Health Technology

Private Unternehmen	3
AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.	Health Technology
Imara, Inc. Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA.	Health Technology
Myovant Sciences, Inc. Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY.	Health Technology